FDA signs off on Adaptimmune's Tecelra as the first engineered cell therapy for a solid tumor
2nd August 2024 Uncategorised 0FDA signs off on Adaptimmune’s Tecelra as the first engineered cell therapy for a solid tumor kdunleavy Fri, 08/02/2024 – 08:14 More: FDA signs off on Adaptimmune's Tecelra as the first engineered cell therapy for a solid tumor Source: fierce
read more

